We help people with cancer and rare diseases live longer, better quality lives
Our Company
Driven by our purpose to redefine cancer care.
Advancing precision care
We harness targeted radiation to help physicians diagnose, stage, and treat cancer with greater precision. Our theranostic approach combines highly specific imaging with targeted therapeutics to enable more personalized treatment and improve outcomes for people living with cancer.
Our impact
Serving Patients
2.9 million
2.9 million
Patients doses delivered each year
Global reach
21
21
Countries with products sold
Clinical innovation
23
23
Active clinical trials and IITs
Our Purpose
Our Mission
To deliver on the promise of precision medicine through targeted radiation
Our values
Everyone counts
We strive to be extraordinary
We act with determination and integrity
Our focuses
Telix is dedicated to delivering diagnostic and therapeutic solutions in areas of high unmet need.
-
Urologic Oncology
Prostate and kidney cancers account for nearly two million new diagnoses globally each year. Many patients face delayed detection or uncertainty during diagnosis, and once disease spreads, treatment options become limited.
Learn more -
Neurologic Oncology
Brain and central nervous system (CNS) cancers remain among the most aggressive and difficult-to-treat malignancies. Glioblastoma (GBM), the most common form, carries a median survival of just over a year with current therapies.
Learn more -
Other Tumors
Soft tissue, bone and blood cancers encompass a diverse group of rare and often aggressive diseases that can be difficult to diagnose and treat.
Learn more
Prostate and kidney cancers account for nearly two million new diagnoses globally each year. Many patients face delayed detection or uncertainty during diagnosis, and once disease spreads, treatment options become limited.
Learn more
Brain and central nervous system (CNS) cancers remain among the most aggressive and difficult-to-treat malignancies. Glioblastoma (GBM), the most common form, carries a median survival of just over a year with current therapies.
Learn more
Soft tissue, bone and blood cancers encompass a diverse group of rare and often aggressive diseases that can be difficult to diagnose and treat.
Learn moreOur leadership
We are led by a global team dedicated to advancing innovative radiopharmaceuticals from discovery through to patient care.
Our Capabilities
Learn more about our capabilities
Therapeutics
Therapeutics are central to Telix’s purpose because they have potential to deliver both improved survival and quality of life.
Precision Medicine
Precision Medicine is developing imaging agents to help ensure a patient’s cancer can be identified and characterized with greater accuracy.
MedTech
MedTech is advancing surgical solutions, software and AI to enhance the performance of our precision medicines and therapeutics.
Telix Manufacturing Solutions (TMS)
Telix Manufacturing Solutions is a global network of facilities designed to deliver patient doses worldwide.